D-Index & Metrics Best Publications

Kohei Miyazono

University of Tokyo
Japan

Molecular Biology

Japan

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Molecular Biology D-index 153 Citations 90,758 541 World Ranking 39 National Ranking 3

Research.com Recognitions

Awards & Achievements

2023 - Research.com Molecular Biology in Japan Leader Award

2022 - Research.com Best Scientist Award

2022 - Research.com Genetics and Molecular Biology in Japan Leader Award

2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study Kohei Miyazono is best known for:

Gene
Transforming growth factor beta
TGF beta signaling pathway

Cell biology connects with themes related to Embryo in his study. His Embryo study frequently links to related topics such as Genetics. His Genetics study frequently links to other fields, such as Messenger RNA. Kohei Miyazono undertakes interdisciplinary study in the fields of Messenger RNA and In situ hybridization through his research. In his papers, he integrates diverse fields, such as In situ hybridization and Molecular biology. He carries out multidisciplinary research, doing studies in Molecular biology and Cell biology. His study ties his expertise on Activator (genetics) together with the subject of Biochemistry. As part of his studies on Activator (genetics), he frequently links adjacent subjects like Receptor. His Receptor study frequently draws parallels with other fields, such as Interleukin-21 receptor.

His most cited work include:

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size (1953 citations)
Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptor (764 citations)
Characterization of Type I Receptors for Transforming Growth Factor-β and Activin (543 citations)

What are the main themes of his work throughout his whole career to date

BMPR2, Bone morphogenetic protein receptor and Bone morphogenetic protein 7 are all intrinsically tied to his study in Bone morphogenetic protein. He performs multidisciplinary study in BMPR2 and Bone morphogenetic protein in his work. A significant part of his In vitro research incorporates Bone morphogenetic protein 2 and Osteoblast studies. His Bone morphogenetic protein 2 study frequently links to other fields, such as Biochemistry. His research links Bone morphogenetic protein 7 with Biochemistry. His Osteoblast study frequently links to adjacent areas such as In vitro. Kohei Miyazono conducted interdisciplinary study in his works that combined Gene and Messenger RNA. Kohei Miyazono merges Messenger RNA with Gene in his study. He undertakes interdisciplinary study in the fields of Cell biology and Molecular biology through his works.

Kohei Miyazono most often published in these fields:

Gene (72.55%)
Cell biology (64.71%)
Biochemistry (64.71%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

Carl-Henrik Heldin;Kohei Miyazono;Peter ten Dijke.
Nature (1997)

4967 Citations

Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

Masao Saitoh;Hideki Nishitoh;Makiko Fujii;Kohsuke Takeda.
The EMBO Journal (1998)

2820 Citations

Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways

Hidenori Ichijo;Eisuke Nishida;Kenji Irie;Peter ten Dijke.
Science (1997)

2740 Citations

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

H. Cabral;Y. Matsumoto;K. Mizuno;Q. Chen.
Nature Nanotechnology (2011)

2138 Citations

Modulation of microRNA processing by p53

Hiroshi I. Suzuki;Kaoru Yamagata;Koichi Sugimoto;Takashi Iwamoto.
Nature (2009)

1536 Citations

TGFβ signalling: a complex web in cancer progression

Hiroaki Ikushima;Kohei Miyazono.
Nature Reviews Cancer (2010)

1383 Citations

ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis

Kei Tobiume;Atsushi Matsuzawa;Takumi Takahashi;Hideki Nishitoh.
EMBO Reports (2001)

1379 Citations

Smad6 inhibits signalling by the TGF-Beta superfamily

Takeshi Imamura;Masao Takase;Ayako Nishihara;Eiichi Oeda.
Nature (1997)

1365 Citations

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Atsuhito Nakao;Takeshi Imamura;Takeshi Imamura;Serhiy Souchelnytskyi;Masahiro Kawabata.
The EMBO Journal (1997)

1291 Citations

Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

Toshio Kitamura;Tsuyoshi Tange;Takashi Terasawa;Shigeru Chiba.
Journal of Cellular Physiology (1989)

1226 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Kohei Miyazono